Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Lilly's Pivotal Phase 3 Atopic Dermatitis Studies
Posted:
Millions of people with atopic dermatitis cope with both seen and unseen burdens of the disease. Discover more about important new clinical trial results and how Lilly is helping to improve care and understanding of this disease here.
The UK Government’s announcement to be an AI superpower will impact every L&D professional’s future.
The UK government announced it’s AI Opportunities Action Plan, which has three key goals:
To lay the foundations for AI
To change lives by embracing AI
To secure the…
Tom Jackson highlights a recent report demonstrating how organisations can incorporate AI within their learning and development practices.
Organisations are using AI solutions to quickly craft tailored learning experiences for each team member and/or team need, making the learning process…
Attendees
Sponsors and
Exhibitors
AI Training
for Doctors Workshops
Contact us